in a company PR, a target projection of 500,000 units sold for 2021 was given. If reached, multiplying by $79/unit = $39.5 m in revenue x 50% margins) = 20m earnings. At 20x earnings (for this growth) = a 400m market cap/1B= $.40 share.
Vitastem – Powerful Super-Healing Topical Antibiotic for Treating Infections, Wounds, Diabetic Ulcers, Bed Sores, Burns, Rashes, Acne and many other skin conditions.
Attorney Letter posted yesterday , Pink Current & Hospital contract incoming…
$VDRM Just the beginning... 👉Debt Free & Self-Sustaining 👉Licensing expansions 👉Sales to top 500,000 units in 2021 👉Purchase orders from: ✅A Large National Hospital Chain ✅A Major Health Insurance Company ✅A Major Midwestern University ✅A Major Global Medical Nonprofit https://t.co/BxRnErqP5Fpic.twitter.com/aEOoB28QYv
$VDRM - I want to buy today near $0.021 too but there just isn't many shares in the float for sale. Smart people have them locked up for dimes and quarters, and I don't blame them with 4 major catalysts coming up shortly!
I have my bids in though! I hope you manage to convince people to sell them cheap. I want some of those shares too. Target short term: $0.10 - $0.15+